FDA cleans Aidoc AI-powered pneumothorax detection tool

Radiology Technology Education Association Aidoc obtained an FDA 510 (k) clearance for his device to diagnose and test for cases of pneumothorax, or lung failure, on X -rays.

Aidoc said the program can run all the X-rays, with handheld devices, and easily record specific cases of pneumothorax so doctors can quickly view these images.

Some of the other FDA products that Aidoc has cleared up with programs for testing and disseminating are pulmonary embolism, examination of cervical spine fractures and diagnosis of acute intracranial hemorrhage.

“We are very excited about this milestone,” CEO Elad Walach said in a statement.

“This FDA approval reaffirms the breadth of our AI platform, going beyond specific AI algorithms to act as a healthcare AI center for the industry’s cross-specialty needs… by bringing radioologists and proceduralists to the same AI level, we can increase collaboration between departments and systems to deliver patients with timely care. “

Why it is

Pneumothorax can be caused by chest pain, certain lung diseases and certain medical conditions, according to the Mayo Clinic. It can be life threatening.

Aidoc positioned his device as a way to quickly detect a falling speed, so no serious problems would arise.

THE GREAT WORK

Less than a year ago, the launch of AI graphics began The $ 66 million was raised in Series C funding, bringing its portfolio to $ 140 million. It came about two years after a $ 27 million Series B deal.

In October, Aidoc joined ScreenPoint Medical i integrates the company’s AI product for 2D and 3D mammography into the Aidoc platform.

Another company that is using AI to help capture Qure.ai, announced yesterday $ 40 million was raised in a fundraiser led by Novo Holdings and HealthQuad. The startup received an FDA 510 (k) earlier this year for an algorithm that uses X-ray boxes to help doctors locate breathing tubes.

Radiology began Sirona Medical also acquired AI powers and some staff from Nines. That procedure involved two FDA -approved instruments, one that examines chest CT scans to determine the size of lung nodules and the other that uses head CT scans to determine the size of the lung nodules. Diagnose intracranial hemorrhage and / or severe side effects.

Related Posts

Leave a Reply

Your email address will not be published.